Pharmacovigilance (PV) Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 9.8 billion
Estimated Base Value
2035 Forecast
US$ 24.7 billion
Projected Market Value
CAGR 2026–2035
9.7%
Compound Annual Growth
Largest Segment
In the full report
Fastest Growing Segment
In the full report
Leading Region
North America
Fastest Growing Region
Asia Pacific
Top Country
In the full report
By Market Share
Largest market
Key Players
PAREXEL
Emerging Players
PrimeVigilance, Veeva Systems
Indicative preview. The market size, forecast and CAGR are our published estimates. The segments, regions, countries and companies on this page show the report's scope; their sizes, shares and growth rates are researched and modelled when the full report is prepared. How our figures are built
Pharmacovigilance (PV) Market Overview
The Pharmacovigilance (PV) Market covers services, software, and systems for detecting, assessing, understanding, and preventing adverse drug reactions and other drug-related problems. It involves systematic monitoring of drug safety throughout the entire product lifecycle, from clinical trials to post-marketing surveillance. This market serves pharmaceutical companies, biotechnology companies, contract research organizations (CROs), and other healthcare stakeholders, helping them ensure patient safety, maintain regulatory compliance, and mitigate drug-associated risks.
The global Pharmacovigilance (PV) market is estimated at $9.8 Bn in 2025 and is forecast to reach $24.7 Bn in 2035, growing at a CAGR of 9.7% from 2025 to 2035. Demand is driven by increasing drug development and product launches, stringent and evolving global pharmacovigilance regulations, and a heightened focus on patient safety outcomes. Conversely, high costs associated with implementing and maintaining PV systems, the complex regulatory landscape, and the challenge of managing vast volumes of safety data act as restraints.
The market is segmented by Type (Clinical Trial Pharmacovigilance Services, Post-Marketing Pharmacovigilance Services, Pharmacovigilance Consulting & Auditing Services, Adverse Event Reporting & Case Management Software, Signal Detection & Management Software, Risk Management & Mitigation Software, Pharmacovigilance Databases & Analytics Tools), Technology (Artificial Intelligence & Machine Learning, Natural Language Processing, Cloud Computing, Big Data Analytics, Robotic Process Automation, Data Mining, Predictive Analytics), Application (Oncology, Cardiovascular Diseases, Neurology, Autoimmune Diseases, Infectious Diseases, Rare Diseases, Vaccines, Others), Source (In-House Pharmacovigilance, Outsourced Pharmacovigilance, Hybrid Pharmacovigilance), End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Medical Device Companies, Academic & Research Institutions, Regulatory Authorities), and Deployment (On-Premise, Cloud-Based, Hybrid). It is served across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Leading companies include PAREXEL, Charles River Laboratories, Medpace, ArisGlobal, PharmaLex, ProPharma Group, Indegene, ProductLife Group, ClinChoice, Navitas Life Sciences, Certara, and Linical Accelovance. The full report covers global market analysis across key regions and countries, focusing on pharmaceutical, biotechnology, and medical device sectors, and includes PV service providers and technology vendors.
Market Definition & Overview
The Pharmacovigilance (PV) Market encompasses the comprehensive range of services, software, and systems dedicated to the detection, assessment, understanding, and prevention of adverse drug reactions and other drug-related problems. It involves systematic monitoring of drug safety throughout the entire product lifecycle, from clinical trials to post-marketing surveillance. This market serves pharmaceutical and biotechnology companies, contract research organizations (CROs), and other healthcare stakeholders to ensure patient safety, maintain regulatory compliance, and mitigate drug-associated risks. Growth is driven by increasing drug development, stringent global regulatory requirements, and the rising need for robust post-market safety monitoring.
Scope
- Global market analysis across key regions and countries
- Focus on pharmaceutical, biotechnology, and medical device sectors
- Coverage of PV service providers and technology vendors
- Market sizing and forecasting from 2025 to 2035
Inclusions
- Adverse Event (AE) case processing and reporting services
- Safety database and PV software solutions
- Risk Management and Minimization Strategies (REMS/RMP)
- Drug safety signal detection and management
- Pharmacovigilance auditing and regulatory compliance
- PV outsourcing services provided by CROs and BPOs
Exclusions
- General clinical trial management systems
- Drug discovery and preclinical research phases
- Pharmaceutical manufacturing process control systems
- Non-safety related healthcare IT solutions
- Market access or commercialization consulting
Market Size Forecast
Executive Summary
- The Pharmacovigilance (PV) market is valued at $9.8 Bn in 2025 and is forecast to reach $24.7 Bn by 2035, reflecting a robust CAGR of 9.7% as demand accelerates across every major segment and region over the ten-year outlook.
- North America leads the market today, while Asia Pacific is expected to grow fastest over the forecast period.
- AI/ML integration and advanced analytics are revolutionizing PV workflows, significantly enhancing signal detection and adverse event reporting efficiency across global regulatory landscapes, driving proactive risk management.
- Intensifying competitive landscape fuels strategic consolidations and partnerships among PV service providers, driven by demand for integrated end-to-end solutions and advanced technology investment to meet global client needs.
- Escalating complexity of novel therapeutics, particularly advanced therapies, necessitates specialized, robust PV frameworks, accelerating innovation in real-world data integration and proactive safety surveillance across all segments.
- Emerging markets represent significant growth frontiers, propelled by expanding pharmaceutical R&D and maturing local regulatory frameworks, demanding agile, localized PV strategies for compliant and effective global market penetration.
- Strategic investments in digital transformation and automation are critical for optimizing PV operational efficiency, improving data integrity, and fostering proactive safety surveillance across the entire global drug safety lifecycle.
- Evolving global regulations increasingly emphasize proactive risk management and continuous benefit-risk assessments, transforming PV from a reactive compliance function into a strategic pillar of comprehensive product lifecycle management.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Value
The global Pharmacovigilance market was valued at $9.8 billion in the base year, underscoring its foundational role in pharmaceutical safety.
Future Market Projection
This market is projected for substantial growth, expected to reach $24.7 billion by the forecast year, driven by increasing drug development and safety regulations.
Strong Growth Rate
The Pharmacovigilance market is poised for robust expansion, exhibiting a Compound Annual Growth Rate (CAGR) of 9.7% through the forecast period.
Regulatory Drivers
Stricter global regulatory requirements for drug safety and adverse event reporting are key factors propelling the market's significant growth across various regions.
Increasing Drug Development
The continuous rise in pharmaceutical R&D activities and new drug approvals worldwide significantly contributes to the expanding demand for pharmacovigilance services.
Digital Transformation Trend
The adoption of advanced technologies like AI and machine learning for data analysis and automation in PV processes represents a notable trend enhancing market efficiency and scope.
Market Dynamics
Market Trends
- AI/ML adoption for enhanced signal detection and analysis.
- Increased digitalization and automation of PV processes.
- Growing integration of real-world data sources into PV.
- Emphasis on proactive and predictive safety monitoring.
Growth Drivers
- Increasing drug development and product launches globally.
- Stringent and evolving global pharmacovigilance regulations.
- Rising incidence of adverse drug reactions requiring monitoring.
- Enhanced global focus on patient safety outcomes.
Restraints
- High costs associated with implementing and maintaining PV systems.
- Complex and evolving global regulatory landscape creates compliance challenges.
- Managing vast volumes of diverse safety data effectively is difficult.
- Shortage of skilled and experienced pharmacovigilance professionals.
Opportunities
- Leveraging advanced technologies like AI, ML, and NLP.
- Expansion of PV services into untapped emerging economies.
- Specialized pharmacovigilance for advanced therapies and biologics.
- Growth in real-world evidence generation for safety insights.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Clinical Trial Pharmacovigilance ServicesPost-Marketing Pharmacovigilance ServicesPharmacovigilance Consulting & Auditing ServicesAdverse Event Reporting & Case Management SoftwareSignal Detection & Management SoftwareRisk Management & Mitigation SoftwarePharmacovigilance Databases & Analytics Tools |
| By Technology | Artificial Intelligence & Machine LearningNatural Language ProcessingCloud ComputingBig Data AnalyticsRobotic Process AutomationData MiningPredictive Analytics |
| By Application | OncologyCardiovascular DiseasesNeurologyAutoimmune DiseasesInfectious DiseasesRare DiseasesVaccinesOthers |
| By Source | In-House PharmacovigilanceOutsourced PharmacovigilanceHybrid Pharmacovigilance |
| By End-User | Pharmaceutical CompaniesBiotechnology CompaniesContract Research OrganizationsMedical Device CompaniesAcademic & Research InstitutionsRegulatory Authorities |
| By Deployment | On-PremiseCloud-BasedHybrid |
Regional Analysis
- North America leads the PV market due to its robust regulatory landscape, particularly driven by the FDA in the US. High pharmaceutical R&D expenditure, advanced healthcare infrastructure, and a large presence of drug manufacturers further solidify its dominant position in drug safety monitoring.
- The Asia-Pacific region is experiencing the fastest growth in the PV market. This surge is attributed to increasing drug consumption, a rise in clinical trials, expanding healthcare access, and the growing trend of outsourcing PV activities to cost-effective countries like India and China.
- An emerging trend across regions is the increasing adoption of advanced technologies like AI and machine learning in pharmacovigilance. These technologies streamline adverse event reporting, data analysis, and signal detection, improving efficiency and accuracy, particularly in highly regulated European and North American markets.
| North America | Latin America | Europe | Asia Pacific | Middle East & Africa |
North America
- North America represents a developing share of this market, with growth shaped by regional demand and investment trends.
Latin America
- A developing market with increasing healthcare spending, growing awareness of drug safety, and harmonization efforts in regulatory guidelines.
- Brazil and Mexico are key contributors, attracting investment in PV infrastructure.
Europe
- Characterized by a robust regulatory framework from the EMA and national agencies, fostering a mature and highly compliant PV market.
- Focus on patient safety and continuous monitoring ensures consistent demand for PV solutions and expertise.
Asia Pacific
- Experiencing rapid growth due to increasing R&D activities, a large patient pool, and evolving regulatory landscapes across countries like China, India, and Japan.
- Outsourcing trends and the rise of local pharmaceutical manufacturers further fuel market expansion.
Middle East & Africa
- Emerging as a significant region for PV driven by increasing foreign investment in healthcare, a growing pharmaceutical industry, and efforts to strengthen regulatory oversight.
- Gulf countries, in particular, are investing heavily in healthcare infrastructure and drug development.
Country Analysis
Market size, share and growth for each country are in the full report. Growth across countries is shaped by local regulatory, infrastructure and demand-side factors specific to each geography.
| Region | Countries covered |
|---|---|
| North America | United States, Canada, Mexico |
| Latin America | Brazil, Argentina |
| Europe | Germany, United Kingdom, Russia, France, Italy, Spain |
| Asia Pacific | China, India, Japan, Malaysia, South Korea, Australia, Taiwan |
| Middle East & Africa | United Arab Emirates, Saudi Arabia, South Africa |
Countries Covered (21)
United States, Canada, Mexico, Brazil, Argentina, Germany, United Kingdom, Russia, France, Italy, Spain, China, India, Japan, Malaysia, South Korea, Australia, Taiwan, United Arab Emirates, Saudi Arabia, South Africa
Competitive Landscape
| Key companies | Key Strategy | Key Products |
|---|---|---|
ArisGlobal | Deliver innovative, AI-powered life sciences R&D software platform solutions to automate core drug development processes and ensure compliance. | LifeSphere SafetyLifeSphere ClinicalLifeSphere Regulatory+1 |
Charles River Laboratories | Offer essential products and services to accelerate research, drug discovery, and development across the pharmaceutical, biotech, and medical device industries. | Discovery ServicesSafety AssessmentProcess Development+1 |
Medpace | Focus on full-service clinical research services, emphasizing therapeutic expertise and high-quality data for complex clinical trials globally. | Clinical Development ServicesRegulatory AffairsPharmacovigilance+1 |
PAREXEL | Provide end-to-end clinical research and consulting services to accelerate drug development and market access for pharmaceutical and biotech clients. | Clinical Development ServicesRegulatory ConsultingPharmacovigilance & Drug Safety+1 |
PharmaLex | Provide comprehensive, integrated regulatory affairs and scientific consulting services to support product development and market access globally. | Pharmacovigilance ServicesRegulatory AffairsQuality Management & Compliance+1 |
Companies Profiled (20)
PAREXEL, Charles River Laboratories, Medpace, ArisGlobal, PharmaLex, ProPharma Group, Indegene, ProductLife Group, ClinChoice, Navitas Life Sciences, Certara, Linical Accelovance, Voisin Consulting Life Sciences, NNIT, Tata Elxsi, MaxisIT, FMD K&L, Lambda Therapeutic Research, Vimta Labs, GVP Solutions
The global Pharmacovigilance (PV) market features a competitive landscape led by PAREXEL, Charles River Laboratories, Medpace, ArisGlobal, PharmaLex, and ProPharma Group, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
PAREXEL
Charles River Laboratories
Medpace
ArisGlobal
PharmaLex
ProPharma Group
Indegene
ProductLife Group
ClinChoice
Navitas Life Sciences
Certara
Linical Accelovance
Voisin Consulting Life Sciences
NNIT
Tata Elxsi
MaxisIT
FMD K&L
Lambda Therapeutic Research
Vimta Labs
GVP Solutions
* Market shares and positioning of each company are in the full report.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Leading Tech Firm Launches AI-Powered PV Platform for Enhanced Safety Monitoring
A prominent health technology company has unveiled its new AI/ML-driven pharmacovigilance platform, designed to significantly improve the accuracy and speed of adverse event detection and signal management. This launch aims to streamline PV operations and reduce the burden of manual review for pharmaceutical companies.
Global CRO Acquires Specialized PV Consulting Firm, Expanding Service Portfolio
A major global Contract Research Organization (CRO) has announced the acquisition of a niche pharmacovigilance consulting firm, strategically enhancing its capabilities in advanced safety reporting and risk management. This move is set to provide more comprehensive end-to-end PV solutions to its growing client base.
Strategic Partnership Formed to Integrate Real-World Data into PV Systems
A leading pharmacovigilance software provider has forged a strategic alliance with a real-world data (RWD) analytics company to seamlessly integrate diverse RWD sources into its PV platforms. This collaboration aims to offer a more holistic and proactive approach to drug safety surveillance post-market authorization.
PV Outsourcing Specialist Secures Significant Investment for Global Expansion and AI Integration
A rapidly growing pharmacovigilance outsourcing specialist has successfully closed a substantial investment round, earmarked for accelerating its global expansion plans and further integrating artificial intelligence into its service offerings. This funding will bolster its capacity to meet the increasing demand for outsourced PV services worldwide.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $9.8 Bn |
| Market Size (Forecast) | $24.7 Bn |
| CAGR | 9.7% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 21 Countries |
| Segments Covered | 6 Segments, 34 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the Pharmacovigilance (PV) Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$6,000 single user · US$8,000 enterprise per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$6,000 single user · US$8,000 enterprise per market · bought online, prepared after your order and emailed to you
See what is inside →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
VP, Corporate Strategy
Industrial manufacturing company
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Director, Investment Research
Private equity firm
“We now use these reports in every planning cycle. The regional granularity, and the same numbers across the report, the dashboard and the Excel, save our team real time.”
Head of Market Intelligence
Specialty chemicals company
Frequently Asked Questions
Common questions about this report and our research
The global Pharmacovigilance (PV) market is estimated at $9.8 Bn in 2025. It is forecast to reach $24.7 Bn in 2035, indicating substantial growth over the forecast period.
The Pharmacovigilance (PV) market is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.7% from 2025 to 2035. This growth reflects increasing demand for drug safety monitoring.
The market is segmented by Type, Technology, Application, Source, End-User, and Deployment. Key areas include Clinical Trial Pharmacovigilance Services, Artificial Intelligence & Machine Learning, Oncology applications, Outsourced Pharmacovigilance, Pharmaceutical Companies as end-users, and Cloud-Based deployment.
Leading companies in the Pharmacovigilance (PV) market include PAREXEL, Charles River Laboratories, Medpace, ArisGlobal, PharmaLex, ProPharma Group, Indegene, ProductLife Group, ClinChoice, Navitas Life Sciences, Certara, and Linical Accelovance.
The report provides global market analysis across key regions and countries. It focuses on pharmaceutical, biotechnology, and medical device sectors, covering PV service providers and technology vendors. It includes market sizing and forecasting from 2025 to 2035.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the interactive dashboard with Excel download, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Prepared and quality-checked by our analysts after your order; our research team will get back to you with the timelines.
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
Pharmacovigilance Market
$8.3 Bn in 2025 · 12.7% CAGR
Pharmacovigilance Software Market
$1.9 Bn in 2025 · 11.6% CAGR
Biopharmaceutical CMO Market
$16.3 Bn in 2025 · 9.6% CAGR
Clinical Trial Recruitment Market
$6.5 Bn in 2025 · 8.4% CAGR
Clinical Trial Supply Chain Market
$5.5 Bn in 2025 · 6.6% CAGR
Contract Research Organization Market
$91.6 Bn in 2025 · 7.1% CAGR
Advanced Cell Manufacturing Market
$5.3 Bn in 2025 · 16.6% CAGR
Advanced Drug Delivery Systems Market
$68.5 Bn in 2025 · 15.4% CAGR
Analysis on Pharmaceuticals
- Market InsightsAI in Healthcare: From Medical Scribes to Protein Design, 12 Markets Sized
Healthcare AI is splitting into dozens of specialised markets. Our estimates show documentation and diagnostics growing fastest.
- Market InsightsPharma Robots Market to 2035: Precision Drives Automation
Pharma robots are moving deeper into pharmaceutical workflows as buyers seek precision, contamination control, and flexible automation across labs and plants.
More Pharmaceuticals research: all Pharmaceuticals market reports · all Viewpoints · Market Insights